retatrutide clinical trial malaysia vs Eloralintide Obesity Therapies from Eli Lilly | Ahmad Bahareth, MD posted on the topic Lilly's 'triple G' agonist triumphs

The Bottom Line Retatrutide leads on trial data, with about 24.2% mean weight loss at 48 weeks against roughly 20.9% for tirzepatide

Bulk sourcing from Chinese manufacturers addresses the cost problem directly, provided the quality holds up under analytical scrutiny

One possibility is dehydration

Anyone considering retatrutide whether through a clinical trial or any other route should consult their GP or a specialist before proceeding, particularly if they are already taking testosterone or any other hormonal therapy

I love, love, love Chrissy, and Brian Rudman, and now my new loves Jackie, Lynn, Erin, and CK rocks

Batth, T